Bulletin of the Korean Chemical Society

  • 제26권2호
  • /
  • Pages.285-291
  • /
  • 2005
  • /
  • 0253-2964(pISSN)
  • /
  • 1229-5949(eISSN)
대한화학회 (Korean Chemical Society)
권호 표지
DOI QR코드

DOI QR Code

Purification and Characterization of HCV RNA-dependent RNA Polymerase from Korean Genotype 1b Isolate: Implications for Discovery of HCV Polymerase Inhibitors

  • 발행 : 2005.02.20
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

The nonstructural protein 5B (NS5B) of hepatitis C virus (HCV) is the viral RNA-dependent RNA polymerase (RdRp), which is the essential catalytic enzyme for the viral replication and is an appealing target for the development of new therapeutic agents against HCV infection. A small amount of serum from a single patient with hepatitis C was used to get the genome of a Korean HCV isolate. Sequence analysis of NS5B 1701 nucleotides showed the genotype of a Korean isolate to be subtype 1b. The soluble recombinant HCV NS5B polymerase lacking the C-terminal 24 amino acids was expressed and purified to homogeneity. With the highly purified NS5B protein, we established in vitro systems for RdRp activity to identify potential polymerase inhibitors. The rhodanine family compounds were found to be potent and specific inhibitors of NS5B from high throughput screening (HTS) assay utilizing the scintillation proximity assay (SPA) system. The binding mode of an inhibitor was analyzed by measuring various kinetic parameters. Lineweaver-Burk plots of the inhibitor suggested it binds not to the active site of NS5B polymerase, but to an allosteric site of the enzyme. The activity of NS5B in in vitro polymerase reactions with homopolymeric RNA requires interaction with multiple substrates that include a template/primer and ribonucleotide triphosphate. Steady-state kinetic parameter, such as Km, was determined for the ribonucleotide triphosphate. One of compounds found interacts directly with the viral polymerase and inhibits RNA synthesis in a manner noncompetitively with respect to UTP. Furthermore, we also investigated the ability of the compound to inhibit NS5B-directed viral RNA replication using the Huh7 cell-based HCV replicon system. The investigation is potentially very useful for the utility of such compounds as anti-hepatitic agents.

키워드

참고문헌

  1. Ali, S.; Tardif, K. D.; Siddiqui, A. J. Virol. 2003, 76, 12001 https://doi.org/10.1128/JVI.76.23.12001-12007.2002
  2. Behrens, S.-E.; Tomei, L.; De Francesco, R. EMBO J. 1996, 15, 12
  3. Rice, C. M. Fields Virology; Fields, B. N.; Knipe, D. M.; Howley, P. M., Eds.; Raven Press: New York, N.Y., 1996; p 931
  4. Seeff, L. B. Am. J. Med. 1999, 107, 10S
  5. World Health Organization. Wkly. Epidemiol. Rec. 1996, 71, 346
  6. Davis, G. L.; Esteban-Mur, R.; Rustgi, V.; Hoefs, J.; Gordon, S. C.; Trepo, C.; Shiffman, M. L.; Zeuzem, S.; Craxi, A.; Ling, M. H.; Albrecht, J. N. Engl. J. Med. 1998, 339, 1493
  7. Fried, M. W.; Shiffman, M.; Reddy, K. R.; Smith, C.; Marinos, G.; Goncales, F. L. J.; Haussinger, D.; Diago, M.; Carosi, G.; Dhumeaux, D.; Craxi, A.; Lin, A.; Hoffman, J.; Yu, J. N. Engl. J. Med. 2002, 347, 975 https://doi.org/10.1056/NEJMoa020047
  8. Choo, Q. L.; Kuo, G.; Weiner, A. J.; Overby, L. R.; Bradley, D. W.; Houghton, M. Science 1989, 244, 359 https://doi.org/10.1126/science.2523562
  9. Lohmann, V.; Korner, F.; Herian, U.; Bartenschlager, R. J. Virol. 1997, 71, 8416
  10. Sambrook, L.; Fritsch, E. F.; Maniatis, T. Molecular Cloning: a Laboratory Manual, 2nd ed.; Cold Spring Harbor Laboratory: Cold Spring Harbor , N.Y. 1989
  11. Krieger, N.; Lohmann, V.; Bartenschlager, R. Journal of Virology 2001, 75, 4614 https://doi.org/10.1128/JVI.75.10.4614-4624.2001
  12. Lohmann, V.; Korner, F.; Koch, J.; Herian, U.; Theilmann, L.; Bartenschlager, R. Science 1999, 285, 110 https://doi.org/10.1126/science.285.5424.110
  13. Hotta, H.; Handajani, R.; Lusida, M. I.; Soemarto, W.; Doi, H.; Miyajima, H.; Homma, M. J. Clin. Microbiol. 1994, 32, 3049
  14. Stuyver, L.; van Arnhem, W.; Wyseur, A.; Hernandez, F.; Delaporte, E.; Maertens, G. Proc. Natl. Acad. Sci. U. S. A. 1994, 91, 10134
  15. Bartenschlager, R. Intervirology 1997, 40, 378 https://doi.org/10.1159/000150570
  16. Guinea, R.; Carrasco, L. EMBO J. 1990, 9, 2011
  17. Morrow, C. D.; Lubinski, J.; Hocko, J.; Gibbons, G. F.; Dasgupta, A. J. Virol. 1985, 53, 266
  18. Neufeld, K. L.; Richards, O. C.; Ehrenfeld, E. J. Biol. Chem. 1991, 266, 24212
  19. Sankar, S.; Porter, A. G. J. Biol. Chem. 1992, 267, 10168
  20. Altamura, S.; Tomei, L.; Koch, U.; Neuner, P.; Summa, V. World Patent No. WO 00/06529, 1999
  21. O'Farrell, D.; Trowbridge, R.; Rowlands, D.; Jager, J. J. Mol. Biol. 2003, 326, 1025 https://doi.org/10.1016/S0022-2836(02)01439-0
  22. Bressanelli, S.; Tomei, L.; Rey, F. A.; De Francesco, R. J. Virol. 2002, 76, 3482 https://doi.org/10.1128/JVI.76.7.3482-3492.2002
  23. Butcher, S. J.; Grimes, J. M.; Makeyev, E. V.; Bamford, D. H.; Stuart, D. I. Nature 2001, 410, 235 https://doi.org/10.1038/35065653

피인용 문헌

  1. Understanding the RNA-Specificity of HCV RdRp: Implications for Anti-HCV Drug Discovery vol.27, pp.1, 2005, https://doi.org/10.5012/bkcs.2006.27.1.059
  2. Thiobarbituric Acid Derivatives for Anti-HCV Agents Targeting NS5B RNA Polymerase vol.28, pp.11, 2005, https://doi.org/10.5012/bkcs.2007.28.11.1917
  3. The Development of Miniaturized Extraction Tool for the Gene Biosensor vol.29, pp.1, 2005, https://doi.org/10.5012/bkcs.2008.29.1.269